Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome-Reference-Cited by-同舟云学术

Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome

Published:2010-02 Issue:2 Volume:86 Page:279-284
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Schneppenheim Reinhard,Frühwald Michael C.,Gesk Stefan,Hasselblatt Martin,Jeibmann Astrid,Kordes Uwe,Kreuz Markus,Leuschner Ivo,Subero Jose Ignacio Martin,Obser Tobias,Oyen Florian,Vater Inga,Siebert Reiner

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics

Reference23 articles.

1. The role of SMARCB1/INI1 in development of rhabdoid tumor;Roberts;Cancer Biol. Ther.,2009

2. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor;Chi;J. Clin. Oncol.,2009

3. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors;Jackson;Clin. Cancer Res.,2009

4. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers;Sévenet;Am. J. Hum. Genet.,1999

5. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer;Versteege;Nature,1998

Cited by 288 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target;Modern Pathology;2024-10

2. Malignant Rhabdoid Tumor and Related Pediatric Tumors: Multimodality Imaging Review with Pathologic Correlation;RadioGraphics;2024-08-01

3. SMARCA4 (BRG1)-deficient carcinoma invading the skull base: report of two cases and literature review;Annals of Medicine & Surgery;2024-05-15

4. Genetic Predisposition to Sarcoma: What Should Clinicians Know?;Current Treatment Options in Oncology;2024-05-07

5. Diffuse infiltrating tumour with the molecular profile of an atypical teratoid rhabdoid tumour (AT/RT SHH‐1B) in an adult patient;Neuropathology and Applied Neurobiology;2024-05-06